Cargando…
GUILLAIN-BARRÉ SYNDROME, OR ACUTE ON CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, FOLLOWING MODERNA COVID-19 VACCINE
Autores principales: | ABO-ZED, ABDELRHMAN, PINEVICH, ANTHONY |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503028/ http://dx.doi.org/10.1016/j.chest.2021.07.838 |
Ejemplares similares
-
POST-INFECTIOUS DEMYELINATING POLYNEUROPATHY SECONDARY TO COVID-19 INFECTION
por: PATTI, RAVIKARAN, et al.
Publicado: (2021) -
BAMLANIVIMAB-INDUCED GUILLAIN-BARRÉ SYNDROME
por: PALAGUACHI, GLADYS, et al.
Publicado: (2021) -
COUGHING UP A LUNG
por: ABO-ZED, ABDELRHMAN, et al.
Publicado: (2021) -
Comparison of ultrasound findings in Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy for differential diagnosis
por: Basiri, Keivan, et al.
Publicado: (2021) -
RESPIRATORY FAILURE SECONDARY TO GUILLAIN–BARRÉ SYNDROME IN COVID-19 INFECTION
por: WILSON, BRANDEN, et al.
Publicado: (2021)